| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2013 | CN101267806B Sustained release of antifectives |
| 08/07/2013 | CN101212969B Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 08/07/2013 | CN101208352B Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 08/07/2013 | CN101080222B Chemically stable compositions of 4-hydroxy tamoxifen |
| 08/06/2013 | US8501994 Acetamide stereoisomer |
| 08/06/2013 | US8501991 P53 activating compounds |
| 08/06/2013 | US8501982 GLP-1 receptor stabilizers and modulators |
| 08/06/2013 | US8501977 Platinum complex and pharmaceutical composition containing the same |
| 08/06/2013 | US8501964 Serotonin reuptake inhibitors |
| 08/06/2013 | US8501961 HIV protease inhibitors and methods for using |
| 08/06/2013 | US8501960 Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof |
| 08/06/2013 | US8501959 Cycloalkane[B]indole antagonists of prostaglandin D2 receptors |
| 08/06/2013 | US8501957 Benzimidazole compounds and their use as anticancer agents |
| 08/06/2013 | US8501955 Acetamide derivatives as glucokinase activators, their process and medicinal application |
| 08/06/2013 | US8501945 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compound |
| 08/06/2013 | US8501944 Inhibitors of protein kinases |
| 08/06/2013 | US8501943 Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| 08/06/2013 | US8501939 Compounds derived from triazine chemistry are known to be useful for the affinity purification of proteins; compounds derivatised with linear, branched or cyclic alkyl groups and devoid of any additional hydrophilic or charged or groups, are especially useful for the purification of proteins with hydroph |
| 08/06/2013 | US8501934 Pyrrolobenzodiazepines |
| 08/06/2013 | US8501821 Method to elicit tomato resistance to fungal disease |
| 08/06/2013 | US8501820 Therapeutic formulation |
| 08/06/2013 | US8501819 Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 08/06/2013 | US8501818 Stabilized compositions of alkylating agents and methods of using same |
| 08/06/2013 | US8501817 Stabilized compositions of alkylating agents and methods of using same |
| 08/06/2013 | US8501816 Antitussive compositions comprising memantine |
| 08/06/2013 | US8501815 Medicaments containing pantothenic acid |
| 08/06/2013 | US8501814 Selective androgen receptor modulators |
| 08/06/2013 | US8501813 γ-secretase inhibitor |
| 08/06/2013 | US8501812 Therapeutic methods for type I diabetes |
| 08/06/2013 | US8501811 TASPASE1 inhibitors and their uses |
| 08/06/2013 | US8501810 Guanidino acetic acid used as an animal food additive |
| 08/06/2013 | US8501809 Inhibitors of α4 mediated cell adhesion |
| 08/06/2013 | US8501808 Foam enhancement of fatty acyl glycinate surfactants |
| 08/06/2013 | US8501807 Pentaerythritol derivatives |
| 08/06/2013 | US8501806 Methods for preventing or reducing colon carcinogenesis |
| 08/06/2013 | US8501805 Substituted alpha-L-bicyclic nucleosides |
| 08/06/2013 | US8501804 Bicyclic compound |
| 08/06/2013 | US8501803 Garcinia derivative, its preparing method and medicinal use |
| 08/06/2013 | US8501802 Co-crystals of duloxetine and COX-INHIBITORs for the treatment of pain |
| 08/06/2013 | US8501801 Organic semiconductor compound, semiconductor element, solar battery, and process for producing organic semiconductor compound |
| 08/06/2013 | US8501800 Controlled-release ophthalmic vehicles |
| 08/06/2013 | US8501799 Pharmaceutical composition containing an N-phenylpyrazole derivative, and use thereof for preparing a topical veterinary for flea control |
| 08/06/2013 | US8501798 Dual-acting antihypertensive agents |
| 08/06/2013 | US8501797 (2-aryl-1H-imidazol-4-yl)-linked heterocycle derivatives |
| 08/06/2013 | US8501796 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure |
| 08/06/2013 | US8501795 (3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives |
| 08/06/2013 | US8501794 Compounds as cannabinoid receptor ligands |
| 08/06/2013 | US8501793 Blood flow promoters for cauda equina tissues |
| 08/06/2013 | US8501792 Treating cancer with desthiazolyl ritonavir |
| 08/06/2013 | US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/06/2013 | US8501790 Compounds for the treatment of proliferative disorders |
| 08/06/2013 | US8501789 Reduces oxidative stresses of the eye; using iron chelate compound |
| 08/06/2013 | US8501788 Process for recovering flunixin from pharmaceutical compositions |
| 08/06/2013 | US8501787 Compounds for the inhibition of angiogenesis and use thereof |
| 08/06/2013 | US8501786 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 08/06/2013 | US8501785 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 08/06/2013 | US8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 08/06/2013 | US8501783 Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| 08/06/2013 | US8501782 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 08/06/2013 | US8501781 Heteroarylpiperidine and -piperazine derivatives |
| 08/06/2013 | US8501780 Indazole carboxamides and their use |
| 08/06/2013 | US8501779 Polymorphs of donepezil salts, preparation methods and uses thereof |
| 08/06/2013 | US8501778 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 08/06/2013 | US8501776 Biphenyl compounds useful as muscarinic receptor antagonists |
| 08/06/2013 | US8501775 Anthelmintics for preventing parasitic infections in humans and animals |
| 08/06/2013 | US8501774 Oxazolidinone-quinolone hybrid antibiotics |
| 08/06/2013 | US8501773 4-fluoro-piperidine T-type calcium channel antagonists |
| 08/06/2013 | US8501772 3,8-diaminotetrahydroquinoline derivative |
| 08/06/2013 | US8501771 Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/06/2013 | US8501770 Substituted imidazopyridinyl-aminopyridine compounds |
| 08/06/2013 | US8501769 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
| 08/06/2013 | US8501767 Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors |
| 08/06/2013 | US8501766 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
| 08/06/2013 | US8501765 Diazacarbazoles and methods of use |
| 08/06/2013 | US8501764 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus) |
| 08/06/2013 | US8501763 Inhibitors of focal adhesion kinase |
| 08/06/2013 | US8501762 Tetrahydroprotoberberine compounds, the synthetic method and the use thereof |
| 08/06/2013 | US8501760 Pharmaceutical compositions comprising nilotinib or its salt |
| 08/06/2013 | US8501759 Use of fibrates |
| 08/06/2013 | US8501757 Substituted phenylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same |
| 08/06/2013 | US8501756 Heterobicyclic carboxamides as inhibitors for kinases |
| 08/06/2013 | US8501755 Tetrahydropyridothienopyrimidine compounds and methods of use thereof |
| 08/06/2013 | US8501754 Quinazolinamide derivatives |
| 08/06/2013 | US8501753 Useful pharmaceutical salts of 7-[(3R, 4R)-3-Hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3, 5-dihydro-pyrrolo [3, 2-D] pyrimidin-4-one |
| 08/06/2013 | US8501752 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines |
| 08/06/2013 | US8501751 Inhibitors of Bruton's tyrosine kinase |
| 08/06/2013 | US8501750 Heterocyclic compound and use thereof |
| 08/06/2013 | US8501749 Azaquinazolinediones chymase inhibitors |
| 08/06/2013 | US8501747 Functionally selective alpha2C adrenoreceptor agonists |
| 08/06/2013 | US8501746 Organic compounds |
| 08/06/2013 | US8501745 Piperazine PDE4 inhibitors and uses thereof |
| 08/06/2013 | US8501744 Piperazine compounds |
| 08/06/2013 | US8501743 Personal care composition |
| 08/06/2013 | US8501742 Method of treating panic disorder |
| 08/06/2013 | US8501741 Optically active compound of prulifloxacin for treating infection and preparation method thereof |
| 08/06/2013 | US8501740 Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors |
| 08/06/2013 | US8501739 Medicaments |
| 08/06/2013 | US8501738 Substituted triazolo-pyridazine derivatives |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501736 Isoquinoline derivatives |